Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOCS: Dexmedetomidine in Cardiovascular Surgery
NCT02237495Phase 3Completed
- Sponsor
- Xijing Hospital
- Start
- Apr 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in heart valve disease (VHD), coronary artery disease (CAD), sponsored by Xijing Hospital. Started Apr 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
heart valve disease (VHD)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02237495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237495.